Local anesthetic with adjuvant alpha-2 agonist

This page covers all Local anesthetic with adjuvant alpha-2 agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Voltage-gated sodium channels (ropivacaine); alpha-2 adrenergic receptors (clonidine), Alpha-2 adrenergic receptor (clonidine); voltage-gated sodium channels (levobupivacaine).

Targets

Voltage-gated sodium channels (ropivacaine); alpha-2 adrenergic receptors (clonidine) · Alpha-2 adrenergic receptor (clonidine); voltage-gated sodium channels (levobupivacaine)

Marketed (2)

• ropivacaine plus clonidine · University Hospital, Lille · Anesthesia
  Ropivacaine blocks sodium channels to provide local anesthesia, while clonidine enhances analgesia by activating alpha-2 adrenergic receptors.
• clonidine, levobupivacaine · University Hospital Dubrava · Anesthesia and Pain Management
  Clonidine is an alpha-2 adrenergic agonist that reduces pain signaling, while levobupivacaine is a local anesthetic that blocks sodium channels to prevent nerve conduction.

Patent intelligence

• local anesthetic with adjuvant alpha 2 agonist patent landscape — aggregated cliff calendar, attackable patents, originator estates